Avet-Loiseau H, Gerson F, Margrangeas F et al. (2001) Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood, 98, 3082-3086.
Billadeau D, Liu P, Jelinek D et al. (1997) Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6. Cancer Research, 57, 2268-2275.
Chesi M, Brents LA, Ely SA et al. (2001) Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood, 97, 729-736.
Corradini P, Ladetto M, Voena C et al. (1993) Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood, 81, 27082713.
Drach J, Ackermann J, Fritz E et al. (1998) Presence ofa p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood, 92, 802-809.
Fonseca R, Price-Troska T, Blood E et al. (2003) Implication of N-ras and K-ras mutation in clinical outcome and biology of multiple myeloma. Blood, 102, 113a.
Ge NL, Rudikoff S. (2000) Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo. Oncogene, 19, 4091-4095.
Guillerm G, Gyan E, Wolowiec D et al. (2001) p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance. Blood, 98, 244-246.
Hyun T, Yam A, Pece S et al. (2000) Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood, 96, 3560-3568.
Kulkarni MS, Daggett JL, Bender TP et al. (2002) Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis. Leukemia, 16, 127-134.
Liu P, Leong T, Quam L et al. (1996) Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood, 88, 2699-2706.
Neri A, Baldini L, Trecca D et al. (1993) p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood, 81, 128-135.
Shou Y, Martelli ML, Gabrea A et al. (2000) Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America, 97, 228-233.
Uchida T, Kinoshita T, Ohno T et al. (2001) Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia. Leukemia, 15, 157-165.
Urashima M, Teoh G, Ogata A et al. (1997) Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia. Clinical Cancer Research, 3, 2173-2179.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.